Reprogramming Metabolism by Targeting UCP2 Halts Leukemia Progression
Acute myeloid leukemia (AML) remains one of the most challenging hematological malignancies, notorious for its aggressive clinical course and frequent...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
Acute myeloid leukemia (AML) remains one of the most challenging hematological malignancies, notorious for its aggressive clinical course and frequent...
In a groundbreaking advancement in hematologic oncology, researchers have unveiled compelling long-term data from the RELAZA2 trial, a multi-center study...
In a landmark announcement at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, two pioneers from...
In a groundbreaking advance that reshapes the landscape of lung cancer treatment, researchers from IRB Barcelona and the Centro de...
In the relentless battle against melanoma, one of the most aggressive and treatment-resistant types of skin cancer, a groundbreaking therapeutic...
The American Cancer Society (ACS) has recently unveiled a significant update to its colorectal cancer (CRC) screening guidelines, a move...
In an era when colorectal cancer represents a daunting public health challenge, particularly as its incidence rises sharply among younger...
In a pivotal advancement for oncology practice and cancer care, the National Comprehensive Cancer Network® (NCCN®), an esteemed consortium of...
In a groundbreaking study that intersects the realms of metabolism and immunotherapy, researchers have unveiled a novel mechanism by which...
In a groundbreaking synthesis of microbial metabolism and host-pathogen interactions, recent research uncovers a compelling metabolic and regulatory nexus between...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine